Transfusional Iron Overload
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08826 | Deferiprone | An iron chelator used to treat patients with transfusional iron overload caused by thalassemia syndromes. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB08826 | Deferiprone | UDP-glucuronosyltransferase 1-6 | enzyme |
| DB08826 | Deferiprone | Iron | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01609 | Deferasirox | 1 | Completed | 1 |
| DB13120 | Deferitazole | 1 | Completed | 1 |
| DB01609 | Deferasirox | 2 | Completed | 4 |
| DB01609 | Deferasirox | 2 | Withdrawn | 1 |
| DB13120 | Deferitazole | 2 | Completed | 1 |
| DB13120 | Deferitazole | 2 | Terminated | 1 |
| DB13120 | Deferitazole | 2 | Withdrawn | 1 |
| DB00746 | Deferoxamine | 2 | Completed | 1 |
| DB01609 | Deferasirox | 4 | Completed | 1 |
| DB01609 | Deferasirox | 4 | Terminated | 1 |